Market Overview
According to DIResearch's in-depth investigation and research, the global Colorectal Cancer Molecular Diagnostics market size will reach 956.03 Million USD in 2025 and is projected to reach 2,361.57 Million USD by 2032, with a CAGR of 13.79% (2025-2032). Notably, the China Colorectal Cancer Molecular Diagnostics market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Colorectal cancer molecular diagnostics refers to a set of advanced laboratory techniques used to analyze and detect specific molecular alterations and biomarkers associated with colorectal cancer. These diagnostics focus on understanding the genetic and molecular characteristics of colorectal tumors, helping healthcare professionals make more accurate diagnoses and tailor personalized treatment plans for patients. The tests involve analyzing patient samples, such as tissue or blood, to identify genetic mutations, gene expressions, and other molecular changes that play a role in the development and progression of colorectal cancer. By providing valuable insights into the molecular profile of each patient's cancer, these diagnostics aid in predicting disease prognosis, guiding treatment decisions, and assessing the patient's response to therapy. Colorectal cancer molecular diagnostics have significantly improved our understanding of the disease and contributed to advancements in precision medicine, leading to more targeted and effective therapies for patients with colorectal cancer.
The major global suppliers of Colorectal Cancer Molecular Diagnostics include Roche Diagnostics, Abbott, Thermo Fisher, Qiagen, Illumina, Biomerieux, Bio-Rad, Agilent, Daangene, Amoydx, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Colorectal Cancer Molecular Diagnostics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Colorectal Cancer Molecular Diagnostics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Colorectal Cancer Molecular Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Colorectal Cancer Molecular Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Colorectal Cancer Molecular Diagnostics Include:
Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Biomerieux
Bio-Rad
Agilent
Daangene
Amoydx
Colorectal Cancer Molecular Diagnostics Product Segment Include:
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Colorectal Cancer Molecular Diagnostics Product Application Include:
Hospital
Third-Party Testing Agency
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Colorectal Cancer Molecular Diagnostics Industry PESTEL Analysis
Chapter 3: Global Colorectal Cancer Molecular Diagnostics Industry Porter's Five Forces Analysis
Chapter 4: Global Colorectal Cancer Molecular Diagnostics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Colorectal Cancer Molecular Diagnostics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Colorectal Cancer Molecular Diagnostics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Colorectal Cancer Molecular Diagnostics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
- 1 Colorectal Cancer Molecular Diagnostics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Colorectal Cancer Molecular Diagnostics Product by Type
- 1.2.1 Polymerase Chain Reaction PCR
- 1.2.2 Molecular Hybridization
- 1.2.3 Biochip
- 1.2.4 Others
- 1.3 Colorectal Cancer Molecular Diagnostics Product by Application
- 1.3.1 Hospital
- 1.3.2 Third-Party Testing Agency
- 1.3.3 Others
- 1.4 Global Colorectal Cancer Molecular Diagnostics Market Size Analysis (2020-2032)
- 1.5 Colorectal Cancer Molecular Diagnostics Market Development Status and Trends
- 1.5.1 Colorectal Cancer Molecular Diagnostics Industry Development Status Analysis
- 1.5.2 Colorectal Cancer Molecular Diagnostics Industry Development Trends Analysis
- 2 Colorectal Cancer Molecular Diagnostics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Colorectal Cancer Molecular Diagnostics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Colorectal Cancer Molecular Diagnostics Market Analysis by Country
- 4.1 Global Colorectal Cancer Molecular Diagnostics Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Colorectal Cancer Molecular Diagnostics Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Colorectal Cancer Molecular Diagnostics Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Colorectal Cancer Molecular Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Colorectal Cancer Molecular Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Colorectal Cancer Molecular Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.5 China Colorectal Cancer Molecular Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.6 France Colorectal Cancer Molecular Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Colorectal Cancer Molecular Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Colorectal Cancer Molecular Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Colorectal Cancer Molecular Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Colorectal Cancer Molecular Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Colorectal Cancer Molecular Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Colorectal Cancer Molecular Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Colorectal Cancer Molecular Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.14 India Colorectal Cancer Molecular Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Colorectal Cancer Molecular Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Colorectal Cancer Molecular Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Colorectal Cancer Molecular Diagnostics Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Colorectal Cancer Molecular Diagnostics Market Revenue by Key Suppliers (2021-2025)
- 5.2 Colorectal Cancer Molecular Diagnostics Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Colorectal Cancer Molecular Diagnostics Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Colorectal Cancer Molecular Diagnostics Market Analysis by Type
- 6.1 Global Colorectal Cancer Molecular Diagnostics Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Colorectal Cancer Molecular Diagnostics Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Roche Diagnostics
- 7.1.1 Roche Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Product Portfolio
- 7.1.3 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Abbott
- 7.2.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Abbott Colorectal Cancer Molecular Diagnostics Product Portfolio
- 7.2.3 Abbott Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Thermo Fisher
- 7.3.1 Thermo Fisher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Thermo Fisher Colorectal Cancer Molecular Diagnostics Product Portfolio
- 7.3.3 Thermo Fisher Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Qiagen
- 7.4.1 Qiagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Qiagen Colorectal Cancer Molecular Diagnostics Product Portfolio
- 7.4.3 Qiagen Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Illumina
- 7.5.1 Illumina Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Illumina Colorectal Cancer Molecular Diagnostics Product Portfolio
- 7.5.3 Illumina Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Biomerieux
- 7.6.1 Biomerieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Biomerieux Colorectal Cancer Molecular Diagnostics Product Portfolio
- 7.6.3 Biomerieux Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Bio-Rad
- 7.7.1 Bio-Rad Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Bio-Rad Colorectal Cancer Molecular Diagnostics Product Portfolio
- 7.7.3 Bio-Rad Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Agilent
- 7.8.1 Agilent Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Agilent Colorectal Cancer Molecular Diagnostics Product Portfolio
- 7.8.3 Agilent Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Daangene
- 7.9.1 Daangene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Daangene Colorectal Cancer Molecular Diagnostics Product Portfolio
- 7.9.3 Daangene Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Amoydx
- 7.10.1 Amoydx Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Amoydx Colorectal Cancer Molecular Diagnostics Product Portfolio
- 7.10.3 Amoydx Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Colorectal Cancer Molecular Diagnostics Industry Chain Analysis
- 8.2 Colorectal Cancer Molecular Diagnostics Product Downstream Application Analysis
- 8.2.1 Global Colorectal Cancer Molecular Diagnostics Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Colorectal Cancer Molecular Diagnostics Revenue and Forecast by Application (2020-2032)
- 8.3 Colorectal Cancer Molecular Diagnostics Typical Downstream Customers
- 8.4 Colorectal Cancer Molecular Diagnostics Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook